1. 105567679 可分泌型TRAIL蛋白构建物和表达载体
CN
11.05.2016
C12N 15/11 Loading...
C12N 15/11
Loading...
201410531197.1
深圳市北科生物科技有限公司
徐明恺
C12N 15/11
Loading...
本发明提供了一种可分泌型TRAIL蛋白构建物和其表达载体。本发明还提供了生产TRAIL蛋白的方法。本发明的慢病毒表达载体可将表达的TRAIL蛋白分泌至宿主细胞外的培养液中，便于收集和纯化，以及更有效地在需要TRAIL蛋白的个体的体内发挥TRAIL蛋白的生理生化作用。
2. 105462913 一种诱导人脐带间充质干细胞分化为胰岛β细胞的方法
CN
06.04.2016
C12N 5/071 Loading...
C12N 5/071
Loading...
201410453617.9
深圳市北科生物科技有限公司
胡祥
C12N 5/071
Loading...
本发明公开了一种利用转基因法诱导分化人脐带间充质干细胞获得胰岛β细胞的方法，使用包含PDX1、MAFA、NGN3、FOXA2、NEUROD1和FGF21胰岛细胞特异基因并连接穿膜信号的腺病毒表达载体，结合多种重组蛋白和小分子，诱导人脐带间充质干细胞定向分化为有功能的胰岛β细胞。本发明的诱导方法简便、易操作、分化效果好。
3. 105456293 一种用于治疗糖尿病的干细胞制剂及其制备方法
CN
06.04.2016
A61K 35/44 Loading...
A61K 35/44
Loading...
201410451828.9
深圳市北科生物科技有限公司
胡祥
A61K 35/44
Loading...
本发明公开了一种用于治疗糖尿病的干细胞制剂，它包含从人脐带中分离提取的间充质干细胞，干细胞的细胞表面标记CD73、CD90、CD105的表达均高于95％，细胞表面标记CD14、CD34、CD45、CD19和HLA-DR的表达均低于3％。该干细胞制剂经诱导能够分化成胰岛β细胞，分泌胰岛素，有效降低血糖浓度，从而为克服糖尿病依赖胰岛素治疗、根治糖尿病提供了新的方法。本发明还提供该干细胞制剂的制备方法，该方法操作简单，原料来源广泛，不受伦理限制，可以进行规模化生产。
4. 105418766 一种用于免疫治疗的EB病毒LMP2A串联表位肽及其应用
CN
23.03.2016
C07K 19/00 Loading...
C07K 19/00
Loading...
201510963795.0
深圳市北科生物科技有限公司
胡祥
C07K 19/00
Loading...
本发明提供了一种用于免疫治疗的EB病毒LMP2A串联表位肽及其应用，所述用于免疫治疗的EB病毒LMP2A串联表位肽为SEQ？ID？NO：1所示的氨基酸序列。采用本发明的技术方案，LMP2A串联表位肽负载人外周血来源的DCs后，可更加有效地促进DCs成熟和递呈能力，使其可以分泌更多的细胞因子；负载了该串联表位肽的DCs与CTL共培养后，诱导出EB病毒特异性的CTL细胞，在体外和体内均可有效地靶向性杀伤鼻咽癌细胞系CNE1，且效果比单独应用LMP2A356-364或LMP2A426-434或两种表位肽混合物的效果更好；为治疗鼻咽癌及EB病毒相关的其它疾病的免疫细胞临床治疗提供了更好的方向。
5. WO/2014/048062 SNP LOCI SET AND USAGE METHOD AND APPLICATION THEREOF
WO
03.04.2014
C12Q 1/68 Loading...
C12Q 1/68
Loading...
PCT/CN2013/001124
FRONTIER LABORATORIES OF SYSTEMS CROP DESIGN CO., LTD.
DENG, Xingwang
C12Q 1/68
Loading...
The present invention discloses a chip for detecting rice genome SNP loci sets, wherein SNP loci are chosen from a nucleotide sequence as represented by SEQ ID NO:1-9000. Said chip can be applied to the analysis of rice germplasm resource genetic fingerprinting, to the identification of genotypes of the offspring of rice hybrids, to the identification of rice varieties and to the selection of rice breeding materials.
6. 103271943 干细胞在制备治疗帕金森病的制剂中的用途
CN
04.09.2013
A61K 35/44 Loading...
A61K 35/44
Loading...
201310166804.4
深圳市北科生物科技有限公司
王小洪
A61K 35/44
Loading...
本发明提供了脐带间质干细胞在制备治疗帕金森病的制剂中的应用。本发明还提供了制备能够用于治疗帕金森病的制剂的脐带间质干细胞的方法以及具有所述干细胞的制剂组合物。利用本发明制备的脐带间质干细胞具有低免疫反应风险，活性高、残留低等优点，并且制备成本低廉。
7. 102329778 转录因子诱导多能干细胞的方法
CN
25.01.2012
C12N 5/10 Loading...
C12N 5/10
Loading...
201110243224.1
深圳市北科生物科技有限公司
胡继繁
C12N 5/10
Loading...
本发明公开了一种转录因子诱导多能干细胞的方法，该方法包括如下步骤：a.在哺乳动物表达载体中提供至少一种人ES细胞转录因子；b.将步骤a的载体转染入指数生长期的人类细胞；c.转染后，分离表达所述载体的细胞；d.将已分离的载体表达细胞培养于板上，直至汇合；e.收集所述载体表达细胞；f.用膜透化溶液和ES细胞提取物处理所述载体表达细胞；g.密封经提取物处理的细胞的膜；h.将经提取物处理的细胞置于悬滴中以生长，并分离成簇的完全重编程的细胞。本发明通过转录因子诱导成功再生出多能干细胞。
8. 102329779 通过mRNA诱导体细胞为多能干细胞的方法
CN
25.01.2012
C12N 5/10 Loading...
C12N 5/10
Loading...
201110243254.2
深圳市北科生物科技有限公司
胡继繁
C12N 5/10
Loading...
本发明公开了一种通过mRNA诱导体细胞为多能干细胞的方法，该方法包括：从小鼠ESC提取mRNA；将所述mRNA包封于至少一种脂质体递送剂中；将体细胞暴露于所述mRNA脂质体；在板或者未涂层培养皿的盖上倒置悬滴培养经暴露的体细胞，持续足以加速细胞聚集的时间；在稀释的琼脂糖凝胶上或者在未涂层的培养皿中混悬培养已聚集的细胞以形成EB；在饲养细胞顶部上或者在涂层板和皿上或者在补充了生长因子的适宜培养基的基质胶上培养EB样细胞；以及选择具有干细胞形态的细胞集落，籍此将所述体细胞去分化为多潜能细胞，用于细胞疗法和化妆品应用。
9. 102329788 细胞转核诱导体细胞成多能二倍体干细胞的方法
CN
25.01.2012
C12N 15/06 Loading...
C12N 15/06
Loading...
201110243239.8
深圳市北科生物科技有限公司
胡继繁
C12N 15/06
Loading...
本发明公开了一种通过ESC细胞与哺乳动物体细胞融合而形成用于自体移植的、多潜能、二倍体ESL细胞的方法，包括如下步骤：a.提供ESC；b.废除ESC中的DNA复制能力；c.将非复制ESC与多个体细胞混合；d.通过向其中加入聚乙二醇，将非复制ESC和体细胞融合；e.将已融合细胞倒置悬滴培养，以生产聚集细胞；f.在稀释的琼脂糖凝胶上混悬培养聚集细胞，以生产EB，持续1-10代；g.在饲养细胞、涂层板和皿、或者在补充了生长因子的适宜培养基中的基质胶上培养EB；而且，h.选择具有与干细胞相同形态学特征并且包含哺乳动物特异性二倍体ESL细胞的、患者特异性ESL细胞的细胞集落。通过本发明的细胞转核诱导，成功使体细胞再生为多能二倍体干细胞。
10. 102301992 用于冻存单个核细胞的冻存液
CN
04.01.2012
A01N 1/02 Loading...
A01N 1/02
Loading...
201110185230.6
深圳市北科生物科技有限公司
吴莉芳
A01N 1/02
Loading...
本发明涉及一种用于冻存单个核细胞的冻存液及其制备方法，属于生物技术领域。用于冻存单个核细胞的冻存液，包含血浆和二甲基亚砜。本发明主要应用于单个核细胞的冻存，具有冻存效果好和节约成本的优点。
11. 102286426 Monocyte culture solution
CN
21.12.2011
C12N 5/078 Loading...
C12N 5/078
Loading...
201110221115.X
Shenzhen Beike Biotech. Co., Ltd.
Huang Xinhua
C12N 5/078
Loading...
The invention provides monocyte culture solution and belongs to the field of biotechnology. The monocyte culture solution comprises Iscove's Modified Dulbecco's Medium (IMDM) basic culture solution, recombinant human insulin, transferrin, beta-mercaptoethanol, recombinant human thrombopoietin, recombinant human stem cell growth factor, rhFlt-3ligand, interleukin6, interleukin3 and recombinant human granulocyte-macrophage colony stimulating factor. The monocyte culture solution provided by the invention is clear in components, and can realize the quick amplification of monocytes and better keep the group property of the monocytes; meanwhile, material and coat are saved. The solution is mainly used for culturing monocytes.
12. 102093981 Method for efficiently inducing reprogramming of human body cells into pluripotent stem cells
CN
15.06.2011
C12N 5/10 Loading...
C12N 5/10
Loading...
201010593844.3
Shenzhen Beike Biotech. Co., Ltd.
Li Tao
C12N 5/10
Loading...
The invention provides a method for efficiently inducing reprogramming of human body cells into pluripotent stem cells, belonging to the field of biomedicine. The method provided by the invention comprises the following step: before carrying out nuclear reprogramming on body cells, culturing the body cells for 2-4 days in a culture medium containing thyroid hormone T3. The method provided by the invention can increase the iPSC (induced pluripotent stem cell) induction efficiency by 20-100 times to about 1.2%, and shorten the induction cycle to 12-16 days; and meanwhile, different clones of the iPSC obtained by induction have uniform cellular morphology, multiplication capacity and pluripotent gene expression, and can be used for researching human diseases.
13. 201850269 气升式生物反应器
CN
01.06.2011
C12M 1/04 Loading...
C12M 1/04
Loading...
200920164122.9
深圳市每人康生物科技有限公司
龚建华
C12M 1/04
Loading...
本实用新型公开了一种气升式生物反应器，包括：罐盖(5)、夹套(6)、罐体(7)、出料管(8)和空气分布管(9)，罐体(7)的外部装有夹套(6)。罐体(7)的下部装有塔形导流环(12)，导流环(12)由上导流环(1)、中导流环(2)和下导流环(3)组成，其直径分别为D1、D2、D3，高度分别为h1、h2、h3，罐体(7)的侧壁下方设有出料管(8)，底部设有空气分布管(9)，加料连接口(10)和衡压连接口(11)装在罐体(7)的上方；罐体(7)内设有上细下粗的多层环间隔件(4)。本反应器有利于细胞菌丝絮团的生长，适用于多种蕈菌菌丝体液体培养。
14. 201832181 一种三维载体
CN
18.05.2011
A61L 27/34 Loading...
A61L 27/34
Loading...
201020256125.8
深圳市北科生物科技有限公司
吴世凯
A61L 27/34
Loading...
本实用新型提供了一种可植入的披膜三维载体，所述三维载体包括载体骨架和披覆于载体骨架内表面的半透膜。本实用新型所述的半透膜不影响小分子的自由交换，但是可以阻止细胞和大分子量蛋白的交换，保证了载体不易被降解，本实用新型的结构简单、经济适用，能有效避免移植过程中产生的免疫反应和排斥反应。
15. 101990888 Stem cell freezing medium and freezing method of stem cells
CN
30.03.2011
C12N 5/074 Loading...
C12N 5/074
Loading...
200910167171.2
Shenzhen Beike Biotech. Co., Ltd.
Dai Guosheng
C12N 5/074
Loading...
The invention provides a stem cell freezing medium and a freezing method of stem cells. The freezing medium contains dimethyl sulfoxide and hydroxyethyl starch and has great clinical application value. The invention also provides the freezing method of stem cells.The stem cell freezing medium in the invention is adopted by the method.In the invention,the cells frozen with the stem cell freezing medium has the advantage of high recovery/survival rate.
16. 101974484 Method for preparing human umbilical cord mesenchymal stem cells
CN
16.02.2011
C12N 5/0775 Loading...
C12N 5/0775
Loading...
201010528733.4
Jiangsu Beike Biotechnology Co., Ltd.
Yang Bing
C12N 5/0775
Loading...
The invention relates to a method for preparing human umbilical cord mesenchymal stem cells, which comprises the steps of collection, transportation, handover, separation, freezing, recovering, primary culture and subculture of umbilical cords. The method has simple process, ensures low production cost, good freezing effect, little cell damage, low toxic side effect and no harm to human body and reduces the residual of the freezing protection liquid in the recovered cells of tissue blocks; and the prepared mesenchymal stem cells can be applied to the clinical treatment of various diseases.
17. 101955881 Airlift bioreactor
CN
26.01.2011
C12M 1/04 Loading...
C12M 1/04
Loading...
200910157925.6
Shenzhen Meirenkang Biological Technology Co., Ltd.
Gong Jianhua
C12M 1/04
Loading...
The invention discloses an airlift bioreactor which comprises a tank cover (5), a jacket (6), a tank body (7), a discharging pipe (8) and an air distributing pipe (9), wherein the jacket (6) is arranged outside the tank body (7). The lower part of the tank body (7) is provided with a tower flow-guiding ring (12), the flow-guiding ring (12) comprises an upper flow-guiding ring (1), a middle flow-guiding ring (2) and a lower flow-guiding ring (3), which respectively have the diameters of D1, D2 and D3 and the heights of h1, h2 and h3; the discharging pipe (8) is arranged below the side wall of the tank body (7), the bottom of the tank body (7) is provided with the air distributing pipe (9), a feeding connecting port (10) and a constant pressure connecting port (11) are arranged above the tank body (7); and a multi-layer ring spacing member (4) with a tapering top-down structure is arranged in the tank body (7). The airlift bioreactor is beneficial to the growth of a cell hypha flocculant and is suitable for the liquid culture of various mushroom myceliums.
18. 101933892 New application of kaempferol extractive and sunscreen cosmetic containing kaempferol extractive
CN
05.01.2011
A61K 8/97 Loading...
A61K 8/97
Loading...
201010263050.0
Aesthetica Biotechnology (Shenzhen) Co., Ltd.
Chen Guang
A61K 8/97
Loading...
The invention discloses a new application of kaempferol extractive and a sunscreen cosmetic containing kaempferol extractive, belonging to the technical field of Chinese traditional medicine and cosmetic, wherein kaempferol extractive has strong ultraviolet absorption in UV-B range, has strong absorption strength, can effectively absorb ultraviolet of sunlight so as to prevent human skin from sun red, sunburn and tanning, can heal photosensitive dermatitis, and can be used as sun screening component of sunscreen cosmetic to be combined with variable sun screening agents to prepare sunscreen skin-care cosmetic. The produced cosmetic has high sunscreen index and is safer than chemical sun screening agent, and has small possibility of allergy effectively. Kaempferol is special medicinal and edible plant at south area, having wide source and plantation in Guangdong, Guangxi and Yunnan.
19. 101897995 Implantable membrane-covering three-dimensional carrier and preparation method thereof
CN
01.12.2010
A61L 27/50 Loading...
A61L 27/50
Loading...
201010224488.8
Shenzhen Sinocells BioTechnologies Co., Ltd.
Wu Shikai
A61L 27/50
Loading...
The invention provides an implantable membrane-covering three-dimensional carrier and a preparation method thereof. The carrier comprises a carrier body and a carrier membrane, wherein the carrier body comprises a biological matrix and an active substance, and the carrier body is wrapped in the carrier membrane. The carrier membrane does not affect free exchange of small molecules, but can prevent the exchange of cells and macromolecular protein so as to ensure that the carrier is not easily degraded. The carrier has a simple, economic and practical structure, and can effectively avoid immunological reaction and exclusive reaction generated in a transplanting process.
20. 101831427 Oligodeoxyribonudeotide for preventing recurrence of tumor and inhibiting tumor growth as well as application thereof
CN
15.09.2010
C12N 15/113 Loading...
C12N 15/113
Loading...
201010137856.5
Graduate School at Shenzhen, Tsinghua University
He Jie
C12N 15/113
Loading...
The invention provides oligodeoxyribonudeotide for preventing tumor recurrence and inhibiting tumor growth as well as an application thereof. The oligodeoxyribonudeotide is in a double-strand structure and comprises a positive-sense strand and an antisense strand. The positive-sense strand has the sequence of 5'-CUGUGCGUGUGACAGCGGCUGA-3', the antisense strand has the sequence of 5'-GACACGCACACUCGCCGACU-3' or 5'-AGCCGCUGUCACACGCACAGUU-3', and the sequence can be chemically modified. The invention also provides a medicine composition containing the sequence and an application of the sequence to the preparation of medicines for preventing tumor recurrence caused by residual tumor cells after tumor extirpation or concurrent chemoradiotherapy and adult tumor growth.
21. 101792776 Recombinant adenovirus vector for efficiently inducing pluripotent stem cell (PS cell), method for inducing PS cell by using recombinant adenovirus vector and usage of recombinant adenovirus vector
CN
04.08.2010
C12N 15/861 Loading...
C12N 15/861
Loading...
200910045714.3
Shenzhen Beike Bio-Technology Co., Ltd.
Li Linfang
C12N 15/861
Loading...
The invention relates to a recombinant adenovirus vector for efficiently inducing a pluripotent stem cell (PS cell) and method for inducing the PS cell by using the recombinant adenovirus vector. The recombinant adenovirus vector is characterized in that the fiber genes therein are B subgroup adenovirus fiber genes, and an Sox2 gene expression cassette and an Oct4 gene expression cassette are connected within the recombinant adenovirus vector in an operating way. The terminally differentiated cell or the adult stem cell of the mammal, particularly the human is infected in vitro, the Oct4 genes and the Sox2 genes are expressed in an ectopic way, and the terminally differentiated cell or the adult stem cell of the mammal, particularly the human can be induced into the PS cell efficiently and rapidly under the synergistic effect of adjusting the epigenetic-inheritance small-molecular medicament. The PS cell of the human can be used for the cell replacement therapy to treat diseases, and the PS cell of the mammal can be used for preparing the transgenic animal model and the animal disease model.
22. 101560495 Method and device for separating single karyocyte
CN
21.10.2009
C12N 5/08 Loading...
C12N 5/08
Loading...
200810089682.2
Shenzhen Beike Biotech Co., Ltd.
Hu Xiang
C12N 5/08
Loading...
The invention provides a method and a device for separating a single karyocyte, in particular a method and a device for separating single karyocyte of cord blood, marrow and peripheral blood. The single karyocyte can be separated without a hundred grades purification environment, and the method and the device are not limited by sample numbers and volumes, and has high efficiency, simple structure and no pollution, thereby being applied to laboratory research and human body treatment, and being easy to produce in batch.
23. 101559254 Method of treating brain damage, device and use
CN
21.10.2009
A61N 1/00 Loading...
A61N 1/00
Loading...
200910132325.4
Wan Qi
Wan Qi
A61N 1/00
Loading...
Provided herein are methods of repairing, treating, managing or preventing brain damages. In some embodiments, the methods comprise applying a direct current electric field to direct or modulate the migration of NSPCs towards the region of the brain damage. In certain embodiments, the methods comprise administering an electric field between a cerebral ventricle and the meninx, inclusive, of the brain where the brain damage occurs. In other embodiments, the methods comprise activating a membrane protein of NSPCs by a direct current electric field. In further embodiments, the methods comprise interactions of a membrane protein in NSPC with Rac1, Tiam1, Pak1, and actin cytoskeleton in a protein complex in the presence of an electric field. In still further embodiments, the methods comprise applying an electric field to promote neurogenesis in the subventricular zone or subgranular zone of the brain.
24. 101506350 Methods for rejuvenating cells in vitro and in vivo
CN
12.08.2009
C12N 5/02 Loading...
C12N 5/02
Loading...
200680046641.4
Hu Jifan
Hu Jifan
C12N 5/02
Loading...
The present invention provides methods for rejuvenating cells, tissues and the whole body. Also provided are rejuvenating buffers and agents as well as kits for rejuvenating cells. Also provided are methods for dedifferentiating somatic cells and differentiating the cells into other cell types.
25. 101450005 Installation method of ventral urgent spinal cord injury animal model
CN
10.06.2009
A61B 19/00 Loading...
A61B 19/00
Loading...
200710077438.X
Shenzhen Beike Bio-technology Co., Ltd.
Yang Bo
A61B 19/00
Loading...
The invention discloses a method for building a ventral acute closed spinal cord-damaged animal model, the steps are that under the condition that any part of the experiment animal body is not cut off, a vertebral column of the animal is beaten by the ventral, two-lower limb movement function of the experiment animal is lost after being beaten, namely the model building is successful. In the invention, the animal is beaten from the ventral, and any part of the experiment animal body is not cut off in the whole process, similar to plural of actual processes of the human body closed spinal cord damage, the built animal model has high reliability and good repeatability.
26. 101392251 Micro RNA capable of inducing stem cell to differentiate toward osteoblasts and use thereof
CN
25.03.2009
C12N 15/11 Loading...
C12N 15/11
Loading...
200810225514.1
Research Institute of Tsinghua University in Shenzhen
Zhang Yaou
C12N 15/11
Loading...
The invention discloses a micro RNA which can induce differentiation from stem cells to osseous cells and an application thereof. The micro RNA disclosed by the invention is one of the following RNAs, namely a double-stranded RNA of a1) or a single-stranded RNA of b1): a1) the nucleotide sequence of one strand is a sequence 1-9 in a sequence table while that of the other strand is a reverse complement to the sequence 1-9 in the sequence table; b1) a recombinant RNA molecule is obtained by connecting a single-stranded RNA with the nucleotide sequence which is the sequence 1-9 in the sequence table and a single-stranded RNA with the nucleotide sequence which is a reverse complement to the sequence 1-9 in the sequence table by a connection sequence; and the connection sequence is TTCAAGAGA. The micro RNA can be used for preparation of medicaments for the treatment of orthopedic disorders and the medicaments can be adopted for the treatment of the orthopedic disorders of osteoporosis, bone fracture, hairline fracture, femoral head necrosis and the like.
27. 201209140 一种细胞培养瓶
CN
18.03.2009
C12M 3/00 Loading...
C12M 3/00
Loading...
200820002790.7
深圳市北科生物科技有限公司
吴世凯
C12M 3/00
Loading...
一种细胞培养瓶，由瓶体和具有密封功能的培养瓶盖组成，还包括在瓶体底部有与瓶体合为一体的突起结构。该突起结构可以是插片状结构、球状结构、半球状结构、椭圆形球状结构、长方体结构、圆锥体状结构或柱状结构。突起结构在培养瓶底部可以是直线型、或S型形状排列。插片状突起结构与培养瓶交接处有若干小孔，以利于培养液充分交换。
28. 1810960 Method of inducing differentiation of human amnion mesenchyme stem cell to nerve cell
CN
02.08.2006
C12N 5/08 Loading...
C12N 5/08
Loading...
200610033008.3
Beike Biological Sci-Tech Co., Ltd., Shenzhen
Hu Xiang
C12N 5/08
Loading...
The present invention is method of inducing differentiation of human human amnion mesenchyme stem cell to nerve cell. The method is to culture human human amnion mesenchyme stem cell in DMEM/F12 culture medium containing all transcofiguration vitamin A acid, basic fibroblast growth factor and ox embryo blood serum. Through the induction of the method, human human amnion mesenchyme stem cell may be differentiated extracorporeally into neure cell. The nerve cell of the present invention and composition containing the nerve cell may be used widely in treating neurogenic diseases.
29. 1810959 Separating and culturing process of human amnion mesenchyme stem cell and its medical composition
CN
02.08.2006
C12N 5/08 Loading...
C12N 5/08
Loading...
200610033007.9
Beike Biological Sci-Tech Co., Ltd., Shenzhen
Hu Xiang
C12N 5/08
Loading...
The present invention is separating and culturing process of human amnion mesenchyme stem cell and its medical composition. The separating and culturing process includes digesting human amnion successively with trypsin, collagenase and deoxyribonuclease, and filtering to prepare single cell suspension; culturing in DMEM/F12 culture medium with VDMEM and VF12 in the equal ratio and containing ox embryo blood serum in 10-20 vol% and basic fibroblast growth factor of ultimate concentration 10-20 ng/ml inside a culture box at 37 deg.c, saturated humidity and CO2 in 5 vol%; and replacing liquid and culture passage to proliferate and purify human amnion mesenchyme stem cell. The process has wide material source no ethnic limitation and wide application foreground. The medical composition may be used in various kinds of treatment.
30. 1363686 Process for screening active components playing weight losing and hypolipemic role from Chinese-herbal medicines
CN
14.08.2002
C12Q 1/02 Loading...
C12Q 1/02
Loading...
02100167.7
Beijing Univ
Zhang Chongben
C12Q 1/02
Loading...
A process for screening the active weight losing-hypolipemic component from Chinese-medicinal materials features that one or more of fatty acid synthetase, acyl-CoA synthetase and the differentiation of mouse and human pre-fat cells to mature fat cells are combined as target of said screening. Its advantages are clear target, and large-scale screening.
31. 1363367 Active components of Chinese-medicinal medicine with weight-losing and hypolipemic actions and its relative medicine
CN
14.08.2002
A61P 3/04 Loading...
A61P 3/04
Loading...
02100168.5
Beijing Univ
Zhang Chongben
A61P 3/04
Loading...
The active hypolipemic components in 40 Chinese-medicinal materials and their relative medicines are disclosed. Said active components can suppress the activity of fatty acid synthetase and the differentiation from profat cells to fat cells and activate the activity of acyl-CoA synthetase. Said medicines feature high effect and low toxic by-effect.

